Print
A Radical New Approach Gaining Attention
A growing number of health educators and practitioners are turning their attention to a surprising contender in the fight against Alzheimer’s disease: Ivermectin.
This antiparasitic drug, long known for its use in treating infections like river blindness, is now being explored for its potential neurological benefits—particularly in protocols developed by Dr. William Makis, a prominent voice in the alternative medicine world.
Dr. Makis has emerged as a leading expert on Ivermectin, using it with patients suffering not only from parasitic infections but also from advanced diseases like cancer and Alzheimer’s.
His results, as reported by supporters and shared widely on social media, have stirred intense curiosity and hope—especially among those who have watched loved ones decline under conventional Alzheimer’s care.
An Unconventional Protocol with Promising Results
Unlike mainstream treatments, which often focus on symptom management through expensive and sometimes toxic pharmaceuticals, Dr. Makis’ Ivermectin protocol aims to address a potential root cause of Alzheimer’s—possible parasitic infection.
Though this theory remains controversial in mainstream circles, alternative practitioners argue that persistent parasites, nanoparticles that act like parasites, and the toxins they produce may contribute to the cognitive decline seen in Alzheimer’s patients.
According to proponents of this protocol, Ivermectin has helped many regain significant cognitive function, in some cases allowing individuals to return to normal daily activities such as golfing, remembering names and events, and living independently without care facility support.
These results stand in stark contrast to the standard trajectory of Alzheimer’s, which typically involves a very progressive loss of memory, motor function, and independence.
The Importance of Proper Usage
Dr. Makis emphasizes that Ivermectin’s effectiveness depends heavily on how it is administered. There are three crucial factors to understand before beginning the protocol.
First, bioavailability is key. Ivermectin must be taken with a meal rich in healthy fats—at least 40 grams—to ensure optimal absorption. These fats can include coconut oil, avocados, olives, butter, cream cheese, grass-fed meats, and fatty fish like wild-caught salmon.
Scientific research shows that when Ivermectin is taken with fat, its absorption is significantly increased compared to when taken on an empty stomach or with low-fat meals.
Second, users must avoid taking binders such as activated charcoal or zeolite on the same day as Ivermectin. These substances, common in many detox protocols, can interfere with Ivermectin’s action by binding to it in the digestive tract, reducing its therapeutic effects.
Third, individuals should be prepared for detox symptoms—also known as Herxheimer reactions—when parasites begin to die off in the body. As Ivermectin targets these organisms, they release toxins like ammonia, uric acid, and even heavy metals.
This can result in temporary flu-like symptoms or fatigue. Far from being a reason to stop, Dr. Makis views this as a sign the treatment is working and suggests complementary strategies for symptom relief, which he details in his educational videos.
How the Protocol Works
The protocol begins with a moderate dose of Ivermectin—typically between 20 and 24 milligrams daily. This amount is taken consistently with a fatty meal and no days off for two to four weeks.
Once the body adapts, the dosage is gradually increased to 35 to 37 milligrams daily for another two weeks. Eventually, patients may work up to a maximum dose of 50 to 60 milligrams per day, depending on their condition and tolerance.
This upper range is similar to what Dr. Makis uses for late-stage cancers, including “turbo cancers,” which are said to progress unusually rapidly. The underlying idea is that parasitic or pathogenic organisms may be fueling these diseases and that aggressive, sustained anti-parasitic treatment is needed to reverse their impact.
A Hopeful Alternative to Conventional Alzheimer’s Care
For many families, traditional Alzheimer’s treatments have yielded disappointing results.
Prescription drugs often carry hefty price tags and offer limited improvement, while also posing risks to the liver and other organs. The Ivermectin approach, by contrast, offers a lower-cost, lower-toxicity alternative—one that may address root causes rather than symptoms.
Of course, this protocol remains outside the mainstream and is not without its critics. Rigorous clinical trials on Ivermectin’s use in Alzheimer’s patients are still lacking, and the theory linking parasitic infection to cognitive decline is far from universally accepted by big pharma and conventional medicine practitioners.
Yet anecdotal evidence from practitioners like Dr. Makis is prompting a re-examination of what’s possible when looking at Alzheimer’s through a new lens.
Understanding the Bigger Picture
Alzheimer’s disease robs people not only of memory but also of dignity, independence, and identity. The emergence of protocols like this one, while controversial, reflects a growing dissatisfaction with the status quo and a hunger for new answers.
If parasites, nanoparticles and chronic infections are indeed playing a role in neurodegeneration, then anti-parasitic agents like Ivermectin could be game-changers—not just for Alzheimer’s, but for a range of chronic illnesses.
As with any medical approach, anyone considering the Ivermectin Alzheimer’s protocol should consult a knowledgeable healthcare provider and proceed with caution, especially given the detox reactions and dosage sensitivity involved. But for those out of options, this emerging strategy may offer a glimmer of hope.
Ask your doctor if Ivermectin is right for you or a family member.
